Cargando…

Exosomes Derived From Epigallocatechin Gallate-Treated Cardiomyocytes Attenuated Acute Myocardial Infarction by Modulating MicroRNA-30a

BACKGROUND: Ischemia-derived exosomes can restrict excessive autophagy by transferring microRNA-30a (miR30a) to cells. Reports have confirmed that epigallocatechin gallate (EGCG) alleviates acute myocardial infarction (AMI) by regulating autophagy; however, research evaluating the communication with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chan, Gan, Xiaowen, Liang, Ronggan, Jian, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054242/ https://www.ncbi.nlm.nih.gov/pubmed/32161548 http://dx.doi.org/10.3389/fphar.2020.00126

Ejemplares similares

MicroRNA-384-5p/Beclin-1 As Potential Indicators For Epigallocatechin Gallate Against Cardiomyocytes Ischemia Reperfusion Injury By Inhibiting Autophagy Via PI3K/Akt Pathway
por: Zhang, Chan, et al.
Publicado: (2019)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs
por: Wang, Chunguang, et al.
Publicado: (2023)

Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
por: Li, Xiaoguang, et al.
Publicado: (2017)

A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo
por: Kuduvalli, Shreyas S., et al.
Publicado: (2023)

Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats
por: ZHONG, WEI, et al.
Publicado: (2015)

Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro
por: Oliviero, Francesca, et al.
Publicado: (2013)

Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro
por: Liu, Shengye, et al.
Publicado: (2018)

Epigallocatechin Gallate During Dietary Restriction — Potential Mechanisms of Enhanced Liver Injury
por: Shi, Zhuo, et al.
Publicado: (2021)

Polyphenol (-)-epigallocatechin gallate targeting myocardial reperfusion limits infarct size and improves cardiac function
por: Kim, Chan Jin, et al.
Publicado: (2010)

Y(6), an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
por: Zhao, Rui-Qiang, et al.
Publicado: (2019)

(-)-Epigallocatechin-3-gallate Ameliorates Intervertebral Disc Degeneration Through Reprogramming of the Circadian Clock
por: Mei, Liangwei, et al.
Publicado: (2021)

Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer
por: Hung, Sze Wan, et al.
Publicado: (2022)

Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition
por: Kim, Sejin, et al.
Publicado: (2023)

Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
por: Jia, Jin-Jing, et al.
Publicado: (2017)

Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
por: Wang, Yumin, et al.
Publicado: (2022)

(-)-Epigallocatechin-3-gallate Reduces Cigarette Smoke-Induced Airway Neutrophilic Inflammation and Mucin Hypersecretion in Rats
por: Liang, Yingmin, et al.
Publicado: (2017)

Epigallocatechin-3-Gallate, the Main Polyphenol in Green Tea, Inhibits Porcine Epidemic Diarrhea Virus In Vitro
por: Huan, Changchao, et al.
Publicado: (2021)

Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation
por: Cione, Erika, et al.
Publicado: (2019)

Role of epigallocatechin-3- gallate in the regulation of known and novel microRNAs in breast carcinoma cells
por: Banerjee, Shrila, et al.
Publicado: (2022)

Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy
por: Farabegoli, Fulvia, et al.
Publicado: (2022)

Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis
por: Ding, Shi-Bin, et al.
Publicado: (2023)

Inhibitory Mechanism of Combined Hydroxychavicol With Epigallocatechin-3-Gallate Against Glioma Cancer Cell Lines: A Transcriptomic Analysis
por: Abdul Rahman, Amirah, et al.
Publicado: (2022)

Epigallocatechin Gallate Attenuates Gentamicin-Induced Nephrotoxicity by Suppressing Apoptosis and Ferroptosis
por: Yue, Lin, et al.
Publicado: (2022)

Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies
por: Wei, Xin-Yu, et al.
Publicado: (2023)

Epigallocatechin-3-Gallate Promotes the Growth of Mink Hair Follicles Through Sonic Hedgehog and Protein Kinase B Signaling Pathways
por: Zhang, Haihua, et al.
Publicado: (2018)

Paeonol Attenuated Inflammatory Response of Endothelial Cells via Stimulating Monocytes-Derived Exosomal MicroRNA-223
por: Liu, Yarong, et al.
Publicado: (2018)

Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
por: Nik Mohamed Kamal, Nik Nur Syazana Binti, et al.
Publicado: (2020)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Determination of (-)-epigallocatechin-3-gallate octaacetate and its metabolites in plasma of rats for pharmacokinetic study by ultra-performance-liquid-chromatography coupled to quadrupole-time-of-flight-mass-spectrometry
por: Chu, Kai On, et al.
Publicado: (2022)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Green Tea Polyphenol Epigallocatechin-3-Gallate Promotes Reendothelialization in Carotid Artery of Diabetic Rabbits by Reactivating Akt/eNOS Pathway
por: Huang, He, et al.
Publicado: (2018)

Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure
por: Sergi, Consolato M.
Publicado: (2020)

Protective effect of epigallocatechin‐3‐gallate against neuroinflammation and anxiety‐like behavior in a rat model of myocardial infarction
por: Wang, Jinpeng, et al.
Publicado: (2020)

Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells
por: Li, Bin-Bin, et al.
Publicado: (2017)

Amelioration of cognitive impairment using epigallocatechin-3-gallate in ovariectomized mice fed a high-fat diet involves remodeling with Prevotella and Bifidobacteriales
por: Qu, Yang, et al.
Publicado: (2023)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

(–)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
por: Wang, Wei, et al.
Publicado: (2018)

Epigallocatechin-3-gallate Mo nanoparticles (EGM NPs) efficiently treat liver injury by strongly reducing oxidative stress, inflammation and endoplasmic reticulum stress
por: Yang, Yunrong, et al.
Publicado: (2022)

Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells
por: Lee, Myung-Yul, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f026lnell4d0sfv56kveaj7p9g